MRI predictors of clinically definite MS based on analyses of placebo patients from the CHAMPS trial

被引：0
|
作者：
Simon, JH
机构：
来源：
NEUROLOGY | 2002年 / 58卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A502 / A503
页数：2
相关论文
共 50 条
  • [31] Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial
    Leist, Thomas P.
    Comi, Giancarlo
    Cree, Bruce A. C.
    Coyle, Patricia K.
    Freedman, Mark S.
    Hartung, Hans-Peter
    Vermersch, Patrick
    Casset-Semanaz, Florence
    Scaramozza, Matthew
    LANCET NEUROLOGY, 2014, 13 (03): : 257 - 267
  • [32] A functional MRI study of patients at presentation with clinically isolated syndromes suggestive of MS
    Rocca, MA
    Codella, M
    Martinelli, V
    Falini, A
    Ghezzi, A
    Rodegher, M
    Scotti, G
    Comi, G
    Filippi, M
    NEUROLOGY, 2002, 58 (07) : A207 - A207
  • [33] Does an altered pattern of cortical activations in patients at presentation with clinically isolated syndromes suggestive of MS influence subsequent evolution to definite MS?
    Filippi, M
    Rocca, MA
    Falini, A
    Ghezzi, A
    Martinelli, V
    Scotti, G
    Comi, G
    NEUROLOGY, 2004, 62 (07) : A494 - A494
  • [34] THE LONG-TERM RISK OF DEVELOPING CLINICALLY DEFINITE MS, RECURRENT MYELITIS AND MRI-SUPPORTED MS AFTER AN ISOLATED EPISODE OF PARTIAL TRANSVERSE MYELITIS
    STEVENS, GHJ
    WEINSTOCKGUTTMAN, B
    KINKEL, RP
    NEUROLOGY, 1995, 45 (04) : A332 - A333
  • [35] Oral Cladribine Delays Time to Conversion to Clinically Definite MS in Patients with a First Demyelinating Event: Top Line Results from the Phase III ORACLE MS Study
    Leist, Thomas
    Comi, Giancarlo
    Cree, Bruce
    Coyle, Patricia
    Freedman, Mark
    Hartung, Hans
    Vermersch, Patrick
    Orejudos, Amelia
    Lachenal, Nathalie
    Scaramozza, Matthew
    NEUROLOGY, 2013, 80
  • [36] Ten-Year Follow-Up of the "Minimal" MS Group from the Original CHAMPS Trial
    Simon, Jack H.
    Kinkel, R. Phillip
    Kollman, Craig
    Dontchev, Mariya
    Powers, Katherine
    O'Connor, Paul
    Foulds, Pamela
    You, Xiaojun
    Hyde, Robert
    NEUROLOGY, 2011, 76 (09) : A70 - A70
  • [37] 1.5 versus 3 Testa MRI of brain: results of a comparison study in patients with clinically definite multiple sclerosis
    Khatri, B.
    Breger, R.
    Anioli, S.
    Kramer, J.
    Dukic, M.
    MULTIPLE SCLEROSIS, 2007, 13 : S75 - S75
  • [38] Patients with clinically isolated syndromes suggestive of MS - Does MRI allow earlier diagnosis?
    Giovannoni, G
    Bever, CT
    NEUROLOGY, 2003, 60 (01) : 6 - 7
  • [39] Combined omics analysis of cerebrospinal fluid is able to predict conversion from clinically isolated syndrome to clinically definite MS within 4 years
    Probert, F.
    Yeo, T.
    Sealey, M.
    Palace, J.
    Leppert, D.
    Kuhle, J.
    Anthony, D. C.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 277 - 278
  • [40] Serum neurofilament light and MRI predictors of cognitive decline in patients with secondary progressive multiple sclerosis: Analysis from the MS-STAT randomised controlled trial
    Williams, Thomas
    Tur, Carmen
    Eshaghi, Arman
    Doshi, Anisha
    Chan, Dennis
    Binks, Sophie
    Wellington, Henny
    Heslegrave, Amanda
    Zetterberg, Henrik
    Chataway, Jeremy
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (12) : 1913 - 1926
12345